Lebwohl, M., Lacour, J.-P., Liljedahl, M., Lynde, C., M?rch, M. H., Tha?i, D. and Warren, R. B. (2020) “Safety of Long-Term Proactive Management with Fixed-Dose Combination Calcipotriene 0.005% and Betamethasone Dipropionate 0.064% Foam in Patients with Psoriasis Vulgaris: Results of a Phase III, Multicentre, Randomized, 52-Week, Vehicle-Controlled Trial”, SKIN The Journal of Cutaneous Medicine, 4(5), p. s31. doi: 10.25251/skin.4.supp.31.